Tenaya Therapeutics, Inc.

TNYA | NASDAQ | 2 Sledující

$0.46

3.51%

$0.02

Sledovat

Overview Metrics Financials

Breakdown	12/31/2024 USD	12/31/2023 USD	12/31/2022 USD	12/31/2021 USD
Total revenue	0 -	0 -	0 -	0 -
Cost of revenue	0 -100.00%	8,687 -0.30%	8,713 +116.47%	4,025 -
Gross profit	0 +100.00%	-8,687 +0.30%	-8,713 -116.47%	-4,025 -
Operating expense	115,948 -11.62%	131,193 +4.44%	125,621 +72.54%	72,806 -
Operating income	-115,948 +11.62%	-131,193 -4.44%	-125,621 -72.54%	-72,806 -
Pretax Income	-111,129 +10.44%	-124,084 -0.34%	-123,665 -70.05%	-72,721 -
Tax Provision	0 -	0 +100.00%	-2 +99.94%	-3,069 -
Net income	-111,129 +10.44%	-124,084 -0.34%	-123,663 -77.54%	-69,652 -
EPS	-1.31 +22.02%	-1.68 +39.13%	-2.76 -63.31%	-1.69 -
Diluted EPS	-1.31 +22.02%	-1.68 +39.13%	-2.76 -63.31%	-1.69 -
Average Shares	84,822 +14.96%	73,786 +64.61%	44,824 +8.55%	41,291 -
Diluted Average Shares	84,822 +14.96%	73,786 +64.61%	44,824 +8.55%	41,291 -
EBIT	0 +100.00%	-131,193 -6.09%	-123,665 -70.05%	-72,721 -
EBITDA	-115,948 +5.35%	-122,506 -6.57%	-114,952 -67.33%	-68,696 -

Soubory cookie používáme ke zlepšení prohlížení na webu.